---
figid: PMC7081367__Dtsch_Arztebl_Int-117_0119_003
figlink: pmc/articles/PMC7081367/figure/F3/
number: F3
caption: 'PI3K/AKT and RAS/RAF signaling pathways with main genes involved.Following
  binding of a growth factor to the corresponding receptor, for example,receptor tyrosine
  kinase (RTK), insulin growth factor 1 receptor (IGF-1R), both signal pathways are
  activated. There is also interaction (crosstalk) between several subsequently activated
  genes.The PI3K/AKT signaling pathway (left) results in increased cell division and
  angiogenesis. The PIK3CA gene encodes for a catalytic subunit (p110α) of phosphatidylinositol-3-kinase
  (PI3K). PIK3CA mutations (usually present in mosaic form) cause PIK3CA-related overgrowth
  spectrum (PROS). This includes megalencephaly capillary malformation (MCAP), hemimegalencephaly,
  fibroadipose overgrowth (FAO), and congenital lipomatous overgrowth, vascular malformations,
  epidermal nevi, and skeletal anomalies (CLOVES). The proteinkinase AKT activates
  mammalian target of rapamycin (mTOR), leading to increased cell division and tissue
  growth. Mosaic mutations in the AKT1 gene are the cause of Proteus syndrome, while
  MTOR mutations are responsible for Smith–Kingsmore syndrome, as well as hemimegalencephaly
  and focal cortical dysplasia. Mutations in the above-mentioned genes are gain-of-function
  mutations. Antagonists of growth activation via the PI3K/AKT signaling cascade include
  PTEN (Cowden syndrome, macrocephaly/autism syndrome, Bannayan–Riley–Ruvalcaba syndrome),
  and tuberous sclerosis (TSC1/2); the loss of which also results in overgrowth due
  to loss-of-function mutations. These mutations are usually not present in mosaic
  form, but are instead constitutional mutations.The RAS/RAF signaling pathway (right)
  regulates the cell cycle, cell differentiation, and apoptosis. Mutations in the
  involved genes result in what are referred to as RASopathies (Noonan syndrome: PTPN11,
  SOS1, RAF1, KRAS, NRAS, SHOC2, CBL genes; Costello syndrome: HRAS gene; cardiofaciocutaneous
  (CFC) syndrome: BRAF, MAP2K1/2). Gain-of-function mutations are found in the above-mentioned
  genes. Neurofibromatosis type 1 (NF1) is a negative regulator of the RAS/RAF signaling
  pathway. As in syndromes associated with the PI3K/AKT signaling pathway, the phenotypic
  overlap is great (, ).'
pmcid: PMC7081367
papertitle: Disorders Caused by Genetic Mosaicism.
reftext: Ute Moog, et al. Dtsch Arztebl Int. 2020 Feb;117(8):119-125.
pmc_ranked_result_index: '28592'
pathway_score: 0.9382147
filename: Dtsch_Arztebl_Int-117_0119_003.jpg
figtitle: Disorders Caused by Genetic Mosaicism
year: '2020'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7081367__Dtsch_Arztebl_Int-117_0119_003.html
  '@type': Dataset
  description: 'PI3K/AKT and RAS/RAF signaling pathways with main genes involved.Following
    binding of a growth factor to the corresponding receptor, for example,receptor
    tyrosine kinase (RTK), insulin growth factor 1 receptor (IGF-1R), both signal
    pathways are activated. There is also interaction (crosstalk) between several
    subsequently activated genes.The PI3K/AKT signaling pathway (left) results in
    increased cell division and angiogenesis. The PIK3CA gene encodes for a catalytic
    subunit (p110α) of phosphatidylinositol-3-kinase (PI3K). PIK3CA mutations (usually
    present in mosaic form) cause PIK3CA-related overgrowth spectrum (PROS). This
    includes megalencephaly capillary malformation (MCAP), hemimegalencephaly, fibroadipose
    overgrowth (FAO), and congenital lipomatous overgrowth, vascular malformations,
    epidermal nevi, and skeletal anomalies (CLOVES). The proteinkinase AKT activates
    mammalian target of rapamycin (mTOR), leading to increased cell division and tissue
    growth. Mosaic mutations in the AKT1 gene are the cause of Proteus syndrome, while
    MTOR mutations are responsible for Smith–Kingsmore syndrome, as well as hemimegalencephaly
    and focal cortical dysplasia. Mutations in the above-mentioned genes are gain-of-function
    mutations. Antagonists of growth activation via the PI3K/AKT signaling cascade
    include PTEN (Cowden syndrome, macrocephaly/autism syndrome, Bannayan–Riley–Ruvalcaba
    syndrome), and tuberous sclerosis (TSC1/2); the loss of which also results in
    overgrowth due to loss-of-function mutations. These mutations are usually not
    present in mosaic form, but are instead constitutional mutations.The RAS/RAF signaling
    pathway (right) regulates the cell cycle, cell differentiation, and apoptosis.
    Mutations in the involved genes result in what are referred to as RASopathies
    (Noonan syndrome: PTPN11, SOS1, RAF1, KRAS, NRAS, SHOC2, CBL genes; Costello syndrome:
    HRAS gene; cardiofaciocutaneous (CFC) syndrome: BRAF, MAP2K1/2). Gain-of-function
    mutations are found in the above-mentioned genes. Neurofibromatosis type 1 (NF1)
    is a negative regulator of the RAS/RAF signaling pathway. As in syndromes associated
    with the PI3K/AKT signaling pathway, the phenotypic overlap is great (, ).'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PIK3CA
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3CB
  - PIK3CD
  - PIK3R5
  - PIK3R6
  - AKT2
  - AKT3
  - AKT1
  - HRAS
  - KRAS
  - NRAS
  - ARAF
  - BRAF
  - RAF1
  - PTEN
  - NF1
  - TSC1
  - TSC2
  - MTOR
  - MAP2K1
  - MAP2K2
  - MAPK3
  - MAPK1
genes:
- word: PI3K/AKT
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PI3K/AKT
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PI3K/AKT
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: PI3K/AKT
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PI3K/AKT
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PI3K/AKT
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PI3K/AKT
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PI3K/AKT
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: PI3K/AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: PI3K/AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: PI3K/AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: PI3K/AKTsignalingpathway
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PI3K/AKTsignalingpathway
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PI3K/AKTsignalingpathway
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: PI3K/AKTsignalingpathway
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PI3K/AKTsignalingpathway
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PI3K/AKTsignalingpathway
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PI3K/AKTsignalingpathway
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PI3K/AKTsignalingpathway
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: RAS/RAFsignalingpathway
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: RAS/RAFsignalingpathway
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: RAS/RAFsignalingpathway
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: RAS/RAF
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: RAS/RAF
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: RAS/RAF
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: RAS/RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: RAS/RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: RAS/RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: PTEN
  symbol: PTEN
  source: hgnc_symbol
  hgnc_symbol: PTEN
  entrez: '5728'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: NF1
  symbol: NF1
  source: hgnc_symbol
  hgnc_symbol: NF1
  entrez: '4763'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: TSC
  symbol: TSC
  source: bioentities_symbol
  hgnc_symbol: TSC1
  entrez: '7248'
- word: TSC
  symbol: TSC
  source: bioentities_symbol
  hgnc_symbol: TSC2
  entrez: '7249'
- word: MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: МЕК
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: МЕК
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
chemicals: []
diseases: []
figid_alias: PMC7081367__F3
redirect_from: /figures/PMC7081367__F3
figtype: Figure
---
